Cosmetic use of poly-l-lactic acid: My technique for success and minimizing complications

Dermatologic Surgery

Volumn 37, Issue 5, 2011, Pages 688-693

  Goldman, Mitchel P ^a  

^a Dermatology & Cosmetic Laser Associates of La Jolla   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; HYALURONIC ACID; POLYLACTIC ACID; STEROID;

ARTICLE; COLLAGEN SYNTHESIS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ESTHETICS; FEMALE; HEMATOMA; HUMAN; INJECTION; INTENSE PULSED LIGHT; LIGHT DAMAGE; LONGEVITY; LOW LEVEL LASER THERAPY; MASSAGE; PATIENT SATISFACTION; PRIORITY JOURNAL; REJUVENATION; SKIN NODULE; SUBCUTANEOUS NODULE; TREATMENT INDICATION;

BIOCOMPATIBLE MATERIALS; CELLULOSE; COSMETIC TECHNIQUES; FACE; HUMANS; INJECTIONS, INTRADERMAL; LACTIC ACID; MANNITOL; POLYMERS; THORAX;

EID: 79955413583     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2011.01975.x     Document Type: Article

References (14)

1. ™. J Drugs Dermatol 2004; 3: 542-7.
2. Vleggaar D., Soft-tissue augmentation and the role of poly-l-lactic acid. Plast Reconstr Surg 2006; 118: 46S.
3. Gogolewski S, Jovanovic M, Perren SM, Dillon JG, et al,. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxy-butyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993; 27: 1135-48.
4. Apikian M, Roberts S, Goodman GJ., Adverse reactions to poly-l-lactic acid injection in the peri-orbital area. J Cosmet Dermatol 2007; 6: 95-101. (Pubitemid 46845418)
5. Hamilton DG, Gauthier N, Robertson BF., Late-onset, recurrent facial nodules associated with injection of poly-l-lactic acid. Dermatol Surg 2008; 34: 123-6. (Pubitemid 350308607)
6. Palm MD, Woodhall KE, Butterwick KJ, Goldman MP., Cosmetic use of poly-L-lactic acid: A retrospective study of 130 patients. Dermatol Surg 2010; 36: 161-70.
7. Peterson J, Goldman MP., Rejuvenation of the aging chest: a review and our experience. Dermatol Surg DOI: 10.1111/j.1524-4725.2011.x.
8. Engelhard P, Humble G, Mest D., Safety of Sculptra: a review of clinical trial data. J Cosmet Laser Ther 2005; 7: 201-5.
9. Lowe NJ, Maxwell CA, Patnaik R., Adverse reactions to dermal fillers: review. Dermatol Surg 2005; 31: 1616-25.
10. Lowe NJ., Dispelling the myth: appropriate use of poly-l-lactic acid and clinical considerations. JEADV 2006; 20: S2-6.
11. Weinkle S., Minimizing the risk of adverse events with injectable poly-l-lactic acid. Int J Dermatol 2008; 6: 11.
12. Lam SM, Azizzadeh B, Graivier M., Injectable poly-l-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg 2006; 118: 55S-63S.
13. Lowe NJ., Optimizing poly-l-lactic acid use. J Cosmet Laser Ther 2008; 10: 43-6. (Pubitemid 351360020)
14. Narins R, Baumann L, Brandt FS, Fagien S, et al,. A randomized study of the efficacy and safety of injectable poly-l-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol 2010; 62: 448-62.